首页> 外文期刊>Journal of Virological Methods >An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.
【24h】

An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.

机译:一种有效的无辅助病毒的方法,用于从适合疫苗开发的细胞系中拯救重组副粘病毒和横纹病毒。

获取原文
获取原文并翻译 | 示例
           

摘要

Recovery of recombinant, negative-strand, nonsegmented RNA viruses from a genomic cDNA clone requires a rescue system that promotes de novo assembly of a functional ribonucleoprotein (RNP) complex in the cell cytoplasm. This is accomplished typically by cotransfecting permissive cells with multiple plasmids that encode the positive-sense genomic RNA, the nucleocapsid protein (N or NP), and the two subunits of the viral RNA-dependent RNA polymerase (L and P). The transfected plasmids are transcribed in the cell cytoplasm by phage T7 RNA polymerase (T7 RNAP), which usually is supplied by infection with a recombinant vaccinia virus or through use of a stable cell line that expresses the polymerase. Although both methods of providing T7 RNAP are effective neither is ideal for viral vaccine development for a number of reasons. Therefore, it was necessary to modify existing technology to make it possible to routinely rescue a variety of recombinant viruses when T7 RNAP was provided by a cotransfected expression plasmid. Development of a broadly applicable procedure required optimization of the helper-virus-free methodology, which resulted in several modifications that improved rescue efficiency such as inclusion of plasmids encoding viral glycoproteins and matrix protein, heat shock treatment, and use of electroporation. The combined effect of these enhancements produced several important benefits including: (1) a helper-virus-free methodology capable of rescuing a diverse variety of paramyxoviruses and recombinant vesicular stomatitis virus (rVSV); (2) methodology that functioned effectively when using Vero cells, a suitable substrate for vaccine production; and (3) a method that enabled rescue of highly attenuated recombinant viruses, which had proven refractory to rescue using published procedures.
机译:从基因组cDNA克隆中恢复重组,负链,无节段的RNA病毒,需要一种挽救系统,该系统可促进细胞核中功能性核糖核蛋白(RNP)复合物从头组装。这通常是通过将许可细胞与编码正向基因组RNA,核衣壳蛋白(N或NP)以及病毒RNA依赖性RNA聚合酶的两个亚基(L和P)的多个质粒共转染来实现的。通过噬菌体T7 RNA聚合酶(T7 RNAP)将转染的质粒转录到细胞质中,通常通过重组牛痘病毒感染或通过使用表达聚合酶的稳定细胞系来提供。尽管提供T7 RNAP的两种方法均有效,但由于多种原因,它们都不是病毒疫苗开发的理想选择。因此,当通过共转染的表达质粒提供T7 RNAP时,有必要对现有技术进行修改,使其有可能例行营救各种重组病毒。开发广泛适用的程序需要优化无辅助病毒的方法,从而进行了多种改进,提高了救援效率,例如包含编码病毒糖蛋白和基质蛋白的质粒,热休克治疗和电穿孔的使用。这些增强的综合效果产生了几个重要的好处,包括:(1)能够拯救多种副粘病毒和重组水疱性口炎病毒(rVSV)的无辅助病毒的方法; (2)使用Vero细胞(疫苗生产的合适基质)时有效发挥作用的方法; (3)一种能够挽救高度减毒的重组病毒的方法,该方法已被证明是使用公开程序难以挽救的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号